• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-环糊精对眼内药物制剂视网膜外植体的细胞毒性。

Cytotoxicity of β-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations.

机构信息

Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, IS-107 Reykjavik, Iceland.

Institute for Ophthalmic Research, University of Tübingen, Elfriede-Aulhorn-Strasse 5-7, 72076 Tübingen, Germany.

出版信息

Molecules. 2021 Mar 9;26(5):1492. doi: 10.3390/molecules26051492.

DOI:10.3390/molecules26051492
PMID:33803405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7967144/
Abstract

Cyclodextrins (CDs) have been widely used as pharmaceutical excipients for formulation purposes for different delivery systems. Recent studies have shown that CDs are able to form complexes with a variety of biomolecules, such as cholesterol. This has subsequently paved the way for the possibility of using CDs as drugs in certain retinal diseases, such as Stargardt disease and retinal artery occlusion, where CDs could absorb cholesterol lumps. However, studies on the retinal toxicity of CDs are limited. The purpose of this study was to examine the retinal toxicity of different beta-(β)CD derivatives and their localization within retinal tissues. To this end, we performed cytotoxicity studies with two different CDs-2-hydroxypropyl-βCD (HPβCD) and randomly methylated β-cyclodextrin (RMβCD)-using wild-type mouse retinal explants, the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, and fluorescence microscopy. RMβCD was found to be more toxic to retinal explants when compared to HPβCD, which the retina can safely tolerate at levels as high as 10 mM. Additionally, studies conducted with fluorescent forms of the same CDs showed that both CDs can penetrate deep into the inner nuclear layer of the retina, with some uptake by Müller cells. These results suggest that HPβCD is a safer option than RMβCD for retinal drug delivery and may advance the use of CDs in the development of drugs designed for intravitreal administration.

摘要

环糊精(CDs)已被广泛用作不同给药系统制剂的药用辅料。最近的研究表明,CDs 能够与多种生物分子(如胆固醇)形成复合物。这为将 CDs 用作某些视网膜疾病(如斯塔加特病和视网膜动脉阻塞)的药物开辟了可能性,在这些疾病中,CDs 可以吸收胆固醇块。然而,关于 CDs 的视网膜毒性的研究有限。本研究旨在研究不同β-(β)CD 衍生物的视网膜毒性及其在视网膜组织内的定位。为此,我们使用野生型小鼠视网膜外植体进行了两种不同的 CD-2-羟丙基-β-CD(HPβCD)和随机甲基化 β-环糊精(RMβCD)的细胞毒性研究,末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)测定和荧光显微镜检查。与 HPβCD 相比,RMβCD 对视网膜外植体的毒性更大,而视网膜可以安全耐受高达 10 mM 的 HPβCD。此外,用相同 CD 的荧光形式进行的研究表明,两种 CD 都可以深入穿透视网膜的内核层,一些被 Müller 细胞摄取。这些结果表明,HPβCD 是用于视网膜药物输送的比 RMβCD 更安全的选择,并可能推进 CDs 在设计用于玻璃体内给药的药物开发中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/56affe0ae0b2/molecules-26-01492-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/ec887d368bfb/molecules-26-01492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/0aab90446e45/molecules-26-01492-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/35b6f2cf6002/molecules-26-01492-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/5a7529b6e463/molecules-26-01492-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/56affe0ae0b2/molecules-26-01492-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/ec887d368bfb/molecules-26-01492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/0aab90446e45/molecules-26-01492-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/35b6f2cf6002/molecules-26-01492-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/5a7529b6e463/molecules-26-01492-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e3/7967144/56affe0ae0b2/molecules-26-01492-g005.jpg

相似文献

1
Cytotoxicity of β-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations.β-环糊精对眼内药物制剂视网膜外植体的细胞毒性。
Molecules. 2021 Mar 9;26(5):1492. doi: 10.3390/molecules26051492.
2
Cyclodextrins: Assessing the Impact of Cavity Size, Occupancy, and Substitutions on Cytotoxicity and Cholesterol Homeostasis.环糊精:评估空腔大小、占据情况和取代基对细胞毒性和胆固醇动态平衡的影响。
Molecules. 2018 May 20;23(5):1228. doi: 10.3390/molecules23051228.
3
Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.环糊精包合物和纳米簇以提高阿苯达唑的溶解度和疗效。
Parasitol Res. 2018 Mar;117(3):705-712. doi: 10.1007/s00436-017-5740-3. Epub 2018 Jan 11.
4
Effect of cyclodextrins on the complexation and nasal permeation of melatonin.环糊精对褪黑素络合及鼻腔渗透的影响。
Drug Deliv. 2008 Aug;15(6):381-8. doi: 10.1080/10717540802006922.
5
The Role of Cyclodextrins against Interface-Induced Denaturation in Pharmaceutical Formulations: A Molecular Dynamics Approach.环糊精在药物制剂中对抗界面诱导变性的作用:一种分子动力学方法。
Mol Pharm. 2021 Jun 7;18(6):2322-2333. doi: 10.1021/acs.molpharmaceut.1c00135. Epub 2021 May 17.
6
Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.双羟萘酸噻嘧啶与 β-、甲基-β-和羟丙基-β-环糊精的二元配合物:包合模式、溶液和固态表征及体外溶出度研究。
Pharm Dev Technol. 2018 Sep;23(7):723-731. doi: 10.1080/10837450.2017.1362435. Epub 2017 Aug 16.
7
Evaluation of the potential toxicity of unmodified and modified cyclodextrins on murine blood-brain barrier endothelial cells.未修饰和修饰的环糊精对小鼠血脑屏障内皮细胞潜在毒性的评估。
J Toxicol Sci. 2016 Apr;41(2):175-84. doi: 10.2131/jts.41.175.
8
Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin.环糊精对布普萘洛尔经大鼠皮肤的络合作用及透皮给药的影响。
Int J Pharm. 2004 Mar 1;271(1-2):155-65. doi: 10.1016/j.ijpharm.2003.11.004.
9
Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.环糊精配合物的自组装:氢化可的松/环糊精配合物的聚集。
Int J Pharm. 2011 Apr 4;407(1-2):174-83. doi: 10.1016/j.ijpharm.2011.01.011. Epub 2011 Jan 13.
10
Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.使用2-羟丙基-β-环糊精眼用溶液向角膜内递送褪黑素用于治疗2型颗粒状角膜营养不良
Int J Pharm. 2017 Aug 30;529(1-2):608-616. doi: 10.1016/j.ijpharm.2017.07.016. Epub 2017 Jul 8.

引用本文的文献

1
Intravitreal drug injection for glaucoma: mechanisms, clinical efficacy, and future horizons.玻璃体内药物注射治疗青光眼:作用机制、临床疗效及未来展望。
Front Pharmacol. 2025 Aug 13;16:1660401. doi: 10.3389/fphar.2025.1660401. eCollection 2025.
2
Preparation, characterization, and in vitro cytogenotoxic evaluation of a novel dimenhydrinate-β-cyclodextrin inclusion complex.新型晕海宁-β-环糊精包合物的制备、表征及体外细胞遗传毒性评价。
Biomol Biomed. 2024 Oct 17;24(6):1637-1650. doi: 10.17305/bb.2024.10507.
3
Pathomechanisms of Inherited Retinal Degeneration and Perspectives for Neuroprotection.

本文引用的文献

1
Cholesterol homeostasis in the vertebrate retina: biology and pathobiology.脊椎动物视网膜中的胆固醇稳态:生物学与病理生物学
J Lipid Res. 2021;62:100057. doi: 10.1194/jlr.TR120000979. Epub 2021 Mar 2.
2
Long-Term, Serum-Free Cultivation of Organotypic Mouse Retina Explants with Intact Retinal Pigment Epithelium.长期、无血清培养具有完整视网膜色素上皮的器官型鼠视网膜片。
J Vis Exp. 2020 Nov 25(165). doi: 10.3791/61868.
3
Cyclodextrins in Parenteral Formulations.环糊精在注射剂中的应用。
遗传性视网膜变性的发病机制及神经保护的展望。
Cold Spring Harb Perspect Med. 2023 Jun 1;13(6):a041310. doi: 10.1101/cshperspect.a041310.
4
Model Systems for Studies Into Retinal Neuroprotection.视网膜神经保护研究的模型系统
Front Neurosci. 2022 Jul 7;16:938089. doi: 10.3389/fnins.2022.938089. eCollection 2022.
5
Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems.研究用于测试玻璃体内脂质体药物递送系统性能的离体动物模型。
Pharmaceutics. 2021 Jul 2;13(7):1013. doi: 10.3390/pharmaceutics13071013.
J Pharm Sci. 2021 Feb;110(2):654-664. doi: 10.1016/j.xphs.2020.10.026. Epub 2020 Oct 15.
4
2-Hydroxypropyl-β-cyclodextrin reduces retinal cholesterol in wild-type and Cyp27a1 Cyp46a1 mice with deficiency in the oxysterol production.2-羟丙基-β-环糊精可降低野生型和缺乏胆甾醇 25-羟化酶/胆固醇 24-羟化酶的 Cyp27a1 Cyp46a1 小鼠的视网膜胆固醇
Br J Pharmacol. 2021 Aug;178(16):3220-3234. doi: 10.1111/bph.15209. Epub 2020 Aug 13.
5
New ophthalmic drug delivery systems.新型眼科药物输送系统。
Farm Hosp. 2020 Jul 1;44(4):149-157. doi: 10.7399/fh.11388.
6
Sulfobutylether-β-cyclodextrin.磺丁基醚-β-环糊精。
Int J Pharm. 2020 Jun 15;583:119396. doi: 10.1016/j.ijpharm.2020.119396. Epub 2020 May 4.
7
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations.眼部后段给药:生物药剂学和药代动力学考量
Pharmaceutics. 2020 Mar 16;12(3):269. doi: 10.3390/pharmaceutics12030269.
8
Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics.超分子环糊精配合物:多样性、安全性及其在眼部治疗中的应用。
Exp Eye Res. 2019 Dec;189:107829. doi: 10.1016/j.exer.2019.107829. Epub 2019 Oct 9.
9
Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin.荧光标记羟丙基-β-环糊精的药代动力学特性。
Biomolecules. 2019 Sep 20;9(10):509. doi: 10.3390/biom9100509.
10
Penetration Enhancers in Ocular Drug Delivery.眼部药物递送中的渗透促进剂
Pharmaceutics. 2019 Jul 9;11(7):321. doi: 10.3390/pharmaceutics11070321.